StockMacro
Menu

Leidos

$122.21 -4.6% in 6 monthsMarket cap $14.9B

LDOS on XNYS, Technology, Leidos Holdings, Inc., job postings

Measures activity, not value. Not investment advice.

Shares fell 34% over 12 months while federal contracts and grants rose to $10.3B from $8.1B.

  • GoodRevenue up 3.6% to $4.6B in the latest quarter
  • WatchCapital spending up 52% to $47M in the same quarter

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 2 Oct 2026

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health management, both domestically and internationally. The customers of the company includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.

Industry
Services-computer integrated systems design (Technology)
Employees
47,000
Website
leidos.com
Listed
NYSE, US
Last results
2 Nov 2026
Next results
expected around 16 Feb 2027 (an estimate: a year ago it reported on 17 Feb 2026)
Revenue and net income per quarter. Quarter to 2 Oct 2026: revenue $4.6B, net income $410.0M.
Quarter to 31 Dec 2021: revenue $3.5B, net income $174.0MQuarter to 31 Dec 2021: revenue $3.5B, net income $174.0MQuarter to 1 Apr 2022: revenue $3.5B, net income $175.0MQuarter to 1 Apr 2022: revenue $3.5B, net income $175.0MQuarter to 1 Jul 2022: revenue $3.6B, net income $171.0MQuarter to 1 Jul 2022: revenue $3.6B, net income $171.0MQuarter to 30 Sep 2022: revenue $3.6B, net income $162.0MQuarter to 30 Sep 2022: revenue $3.6B, net income $162.0MQuarter to 30 Dec 2022: revenue $3.7B, net income $177.0MQuarter to 30 Dec 2022: revenue $3.7B, net income $177.0MQuarter to 31 Mar 2023: revenue $3.7B, net income $162.0MQuarter to 31 Mar 2023: revenue $3.7B, net income $162.0MQuarter to 30 Jun 2023: revenue $3.8B, net income $207.0MQuarter to 30 Jun 2023: revenue $3.8B, net income $207.0MQuarter to 29 Sep 2023: revenue $3.9B, net income -$399.0MQuarter to 29 Sep 2023: revenue $3.9B, net income -$399.0MQuarter to 29 Dec 2023: revenue $4.0B, net income $229.0MQuarter to 29 Dec 2023: revenue $4.0B, net income $229.0MQuarter to 29 Mar 2024: revenue $4.0B, net income $284.0MQuarter to 29 Mar 2024: revenue $4.0B, net income $284.0MQuarter to 28 Jun 2024: revenue $4.1B, net income $322.0MQuarter to 28 Jun 2024: revenue $4.1B, net income $322.0MQuarter to 27 Sep 2024: revenue $4.2B, net income $364.0MQuarter to 27 Sep 2024: revenue $4.2B, net income $364.0MQuarter to 3 Jan 2025: revenue $4.4B, net income $284.0MQuarter to 3 Jan 2025: revenue $4.4B, net income $284.0MQuarter to 4 Apr 2025: revenue $4.2B, net income $363.0MQuarter to 4 Apr 2025: revenue $4.2B, net income $363.0MQuarter to 4 Jul 2025: revenue $4.3B, net income $391.0MQuarter to 4 Jul 2025: revenue $4.3B, net income $391.0MQuarter to 3 Oct 2025: revenue $4.5B, net income $367.0MQuarter to 3 Oct 2025: revenue $4.5B, net income $367.0MQuarter to 2 Jan 2026: revenue $4.2B, net income $327.0MQuarter to 2 Jan 2026: revenue $4.2B, net income $327.0MQuarter to 3 Apr 2026: revenue $4.4B, net income $328.0MQuarter to 3 Apr 2026: revenue $4.4B, net income $328.0MQuarter to 3 Jul 2026: revenue $4.6B, net income $354.0MQuarter to 3 Jul 2026: revenue $4.6B, net income $354.0MQuarter to 2 Oct 2026: revenue $4.6B, net income $410.0MQuarter to 2 Oct 2026: revenue $4.6B, net income $410.0M
31 Dec 2021RevenueNet incomeNet losstallest bar $4.6B2 Oct 2026
See the numbers
Quarter toRevenueNet income
2 Oct 2026$4.6B$410.0M
3 Jul 2026$4.6B$354.0M
3 Apr 2026$4.4B$328.0M
2 Jan 2026$4.2B$327.0M
3 Oct 2025$4.5B$367.0M
4 Jul 2025$4.3B$391.0M
4 Apr 2025$4.2B$363.0M
3 Jan 2025$4.4B$284.0M
27 Sep 2024$4.2B$364.0M
28 Jun 2024$4.1B$322.0M
29 Mar 2024$4.0B$284.0M
29 Dec 2023$4.0B$229.0M
29 Sep 2023$3.9B-$399.0M
30 Jun 2023$3.8B$207.0M
31 Mar 2023$3.7B$162.0M
30 Dec 2022$3.7B$177.0M
30 Sep 2022$3.6B$162.0M
1 Jul 2022$3.6B$171.0M
1 Apr 2022$3.5B$175.0M
31 Dec 2021$3.5B$174.0M
Fundamentals, 12 months to 2 Oct 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $17.8B $17.3B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +2.7% +4.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $1.4B $1.4B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $11.17 $10.69
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 17.6% 17.6% 39.9%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 11.5% 11.9% 0.2%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 8.0% 8.1% 2.3%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 28.2% 5.0%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $630.0M $974.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $6.0B $4.7B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $5.4B $3.7B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 1.2 0.36
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $42.40
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 10.5 24.1
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.84 1.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.1 1.9
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.9 2.4
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 1.3% 1.4%

Latest = 12 months to 2 Oct 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
LeidosLDOS (this company) $14.9B10.50.84+2.7%8.0%
Caci International CLACACI $13.1B24.11.3+10%5.5%
GoDaddyGDDY $12.1B12.62.3+6.4%18.6%
Henry (Jack) & AssociatesJKHY $11.9B23.04.6+7.5%20.0%
SamsaraIOT $22.0B24211.9+30%4.9%
IonQIONQ $9.6B35.123.6+377%67.1%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$440K

bought $0, sold $440K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+8.2%

809 13F filers vs 748

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

77%

94.4M shares held by 13F filers (30 Sep 2026) of 122.0M outstanding (27 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.2%

3.9M shares sold short (30 Oct 2026) of 122.0M outstanding (27 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.5

3.9M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-10%

4.4M shares sold short in the report before, 3.9M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

41%

41% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 54%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

50K

reported for the year to 2 Oct 2026; +6.4% on the year before (47K)

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+3.6%

$4.6B vs $4.5B (quarter ended 2 Oct 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+52%

$47.0M vs $31.0M (quarter ended 2 Oct 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$10.3B

the 12 months before: $8.1B

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$5.2M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

31

31 articles in the last 7 days; its usual week has 6 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.2×

31 articles in the last 7 days; its usual week has 6.

Price $122.21 on 20 Nov 2026, -34% over 12 months (12-month range $100.00 to $198.34)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $3.5M in the last 12 months (the 12 months before: -$7.5M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 15 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $4.6B in the latest quarter, +3.6% on a year earlier.
Capital spending per quarter. Capital spending $47.0M in the latest quarter, +52% on a year earlier.
Institutional holders (13F filers). 809 13F filers reported holding it in the latest 13F quarter, -5.5% on a year earlier.
Federal obligations. Federal obligations: $10.0B published in the last 12 months, +6.8% on the 12 months before.
Lobbying spend. Lobbying spend: $5.2M published in the last 12 months, +11% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
1 Oct 20268-K and other filingsDirector or officer change
1 Oct 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Aug 2026Sharp changeLobbying on a new issue: lobbying on a new issue: AVI, HOM, INT, TAX, VET (2026-06-30)
6 May 20268-K and other filingsDirector or officer change
6 May 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 May 2026Lobbying filinglobbying engagement terminated (FOX POTOMAC RESOURCES, LLC)
20 Apr 2026Lobbying filinglobbying engagement terminated (POTOMAC CAPITOL ASSOCIATES, INC.)
30 Mar 20268-K and other filingsCompleted an acquisition or asset sale
18 Nov 2025Sharp changeMany funds opening a new position: many funds opening a new position, 132 vs usual 96 (2025-09-30); 1.2x the same period a year earlier
29 Apr 2025Sharp changeShort interest spike: short interest spike, 4.3M vs usual 1.8M (2025-04-15); 3.0x the same period a year earlier
15 Apr 2025Sharp changeShort interest spike: short interest spike, 5.3M vs usual 1.6M (2025-03-31); 4.0x the same period a year earlier
1 Apr 2025Sharp changeShort interest spike: short interest spike, 6.0M vs usual 1.5M (2025-03-14); 6.2x the same period a year earlier
18 Mar 2025Sharp changeShort interest spike: short interest spike, 5.9M vs usual 1.5M (2025-02-28); 5.6x the same period a year earlier
4 Mar 2025Sharp changeShort interest spike: short interest spike, 3.4M vs usual 1.5M (2025-02-14); 3.3x the same period a year earlier
28 Feb 2025Lobbying filingnew lobbying registration (CGCN GROUP, LLC)
19 Feb 2025Lobbying filingnew lobbying registration (SQUIRE PATTON BOGGS)
18 Feb 2025Sharp changeShort interest spike: short interest spike, 3.3M vs usual 1.4M (2025-01-31); 2.7x the same period a year earlier
28 Jan 2025Sharp changeShort interest spike: short interest spike, 3.1M vs usual 1.4M (2025-01-15); 2.3x the same period a year earlier
14 Jan 2025Sharp changeShort interest spike: short interest spike, 3.1M vs usual 1.4M (2024-12-31); 2.3x the same period a year earlier
14 Jan 20258-K and other filingsDirector or officer change
31 Dec 2024Sharp changeShort interest spike: short interest spike, 3.2M vs usual 1.4M (2024-12-13); 2.9x the same period a year earlier
17 Dec 2024Sharp changeShort interest spike: short interest spike, 2.6M vs usual 1.4M (2024-11-29); 2.3x the same period a year earlier
25 Oct 20248-K and other filingsDirector or officer change
18 Sep 20248-K and other filingsDirector or officer change
18 Sep 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Aug 2024Lobbying filingnew lobbying registration (FOX POTOMAC RESOURCES, LLC)
18 Aug 2024Sharp changeFirst award from a new federal agency: first award from a new federal agency (Millennium Challenge Corporation): 1901 GROUP, LLC: new Millennium Challenge Corporation contract 95332424F0075 ($5,940,102)
29 Mar 2024Lobbying filinglobbying engagement terminated (REPUBLIC CONSULTING, LLC)
17 Jan 20248-K and other filingsDirector or officer change
14 Dec 20238-K and other filingsDirector or officer change
1 Nov 20238-K and other filingsDirector or officer change
1 Nov 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 May 2023Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 500K)
4 Apr 2023Lobbying filingnew lobbying registration (535 GROUP, LLC)
3 Apr 2023Lobbying filingnew lobbying registration (REPUBLIC CONSULTING, LLC)
14 Mar 20238-K and other filingsA major agreement ended
27 Feb 20238-K and other filingsDirector or officer change
27 Feb 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Feb 2023Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 53.0M vs usual 26.5M (2022-12-30); 1.6x the same period a year earlier
20 Jan 2023Lobbying filinglobbying engagement terminated (INNOVATIVE FEDERAL STRATEGIES, LLC)
3 Jan 2023Lobbying filingnew lobbying registration (PARK GOVERNMENT RELATIONS, LLC)
3 Jan 2023Lobbying filinglobbying engagement terminated (PARK GOVERNMENT RELATIONS, LLC)
10 May 2022Lobbying filingnew lobbying registration (CR FEDERAL)
10 May 2022Lobbying filinglobbying engagement terminated (CAPITOL RESOURCES, LLC)
12 Apr 2022Sharp changeShort interest spike: short interest spike, 3.9M vs usual 1.8M (2022-03-31); 2.6x the same period a year earlier
29 Mar 2022Sharp changeShort interest spike: short interest spike, 5.0M vs usual 1.8M (2022-03-15); 2.4x the same period a year earlier
15 Mar 2022Sharp changeShort interest spike: short interest spike, 6.6M vs usual 1.7M (2022-02-28); 3.2x the same period a year earlier
15 Mar 2022Lobbying filingnew lobbying registration (TEAM HALLAHAN LLC)
15 Mar 2022Lobbying filingnew lobbying registration (AVISE SOLUTIONS)
16 Feb 20228-K and other filingsDirector or officer change
16 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 Jan 2022Lobbying filingnew lobbying registration (PARK GOVERNMENT RELATIONS, LLC)
Insider net buying (open market)
Month from 1 Feb 2022: -$214K published
Month from 1 Mar 2022: -$6.6M published
Month from 1 May 2022: -$747K published
Month from 1 Jun 2022: -$801K published
Month from 1 Aug 2022: -$320K published
Month from 1 Nov 2022: -$6.9M published
Month from 1 Dec 2022: -$3.0M published
Month from 1 May 2023: $790K published
Month from 1 Aug 2023: -$300K published
Month from 1 Nov 2023: -$1.4M published
Month from 1 Feb 2024: -$342K published
Month from 1 Mar 2024: -$1.0M published
Month from 1 May 2024: -$837K published
Month from 1 Aug 2024: -$50K published
Month from 1 Nov 2024: -$636K published
Month from 1 Feb 2025: -$483K published
Month from 1 May 2025: -$193K published
Month from 1 Aug 2025: -$4.6M published
Month from 1 Sep 2025: -$2.2M published
Month from 1 Dec 2025: -$543K published
Month from 1 Jan 2026: -$577K published
Month from 1 Apr 2026: -$318K published
Month from 1 May 2026: -$197K published
Month from 1 Aug 2026: -$1.4M published
Month from 1 Sep 2026: -$141K published
Month from 1 Nov 2026: -$299K published
H-1B/E-3 applications certified
Quarter from 1 Oct 2026: 15 published
Revenue per quarter
Quarter ended 31 Dec 2021: $3.5B, +7.3% on a year earlier; public on 16 Feb 2022
Quarter ended 1 Apr 2022: $3.5B, +5.4% on a year earlier; public on 4 May 2022
Quarter ended 1 Jul 2022: $3.6B, +4.3% on a year earlier; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $3.6B, +3.6% on a year earlier; public on 2 Nov 2022
Quarter ended 30 Dec 2022: $3.7B, +5.9% on a year earlier; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $3.7B, +5.9% on a year earlier; public on 3 May 2023
Quarter ended 30 Jun 2023: $3.8B, +6.7% on a year earlier; public on 2 Aug 2023
Quarter ended 29 Sep 2023: $3.9B, +8.7% on a year earlier; public on 1 Nov 2023
Quarter ended 29 Dec 2023: $4.0B, +7.7% on a year earlier; public on 14 Feb 2024
Quarter ended 29 Mar 2024: $4.0B, +7.5% on a year earlier; public on 1 May 2024
Quarter ended 28 Jun 2024: $4.1B, +7.7% on a year earlier; public on 31 Jul 2024
Quarter ended 27 Sep 2024: $4.2B, +6.9% on a year earlier; public on 30 Oct 2024
Quarter ended 3 Jan 2025: $4.4B, +9.7% on a year earlier; public on 12 Feb 2025
Quarter ended 4 Apr 2025: $4.2B, +6.8% on a year earlier; public on 7 May 2025
Quarter ended 4 Jul 2025: $4.3B, +2.9% on a year earlier; public on 6 Aug 2025
Quarter ended 3 Oct 2025: $4.5B, +6.7% on a year earlier; public on 5 Nov 2025
Quarter ended 2 Jan 2026: $4.2B, -3.6% on a year earlier; public on 18 Feb 2026
Quarter ended 3 Apr 2026: $4.4B, +3.7% on a year earlier; public on 6 May 2026
Quarter ended 3 Jul 2026: $4.6B, +7.2% on a year earlier; public on 5 Aug 2026
Quarter ended 2 Oct 2026: $4.6B, +3.6% on a year earlier; public on 4 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $33.0M, -48% on a year earlier; public on 16 Feb 2022
Quarter ended 1 Apr 2022: $28.0M, +7.7% on a year earlier; public on 4 May 2022
Quarter ended 1 Jul 2022: $21.0M, 0% on a year earlier; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $27.0M, +12% on a year earlier; public on 2 Nov 2022
Quarter ended 30 Dec 2022: $53.0M, +61% on a year earlier; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $39.0M, +39% on a year earlier; public on 3 May 2023
Quarter ended 30 Jun 2023: $40.0M, +90% on a year earlier; public on 2 Aug 2023
Quarter ended 29 Sep 2023: $50.0M, +85% on a year earlier; public on 1 Nov 2023
Quarter ended 29 Dec 2023: $78.0M, +47% on a year earlier; public on 14 Feb 2024
Quarter ended 29 Mar 2024: $17.0M, -56% on a year earlier; public on 1 May 2024
Quarter ended 28 Jun 2024: $23.0M, -43% on a year earlier; public on 31 Jul 2024
Quarter ended 27 Sep 2024: $23.0M, -54% on a year earlier; public on 30 Oct 2024
Quarter ended 3 Jan 2025: $86.0M, +10% on a year earlier; public on 12 Feb 2025
Quarter ended 4 Apr 2025: $22.0M, +29% on a year earlier; public on 7 May 2025
Quarter ended 4 Jul 2025: $29.0M, +26% on a year earlier; public on 6 Aug 2025
Quarter ended 3 Oct 2025: $31.0M, +35% on a year earlier; public on 5 Nov 2025
Quarter ended 2 Jan 2026: $43.0M, -50% on a year earlier; public on 18 Feb 2026
Quarter ended 3 Apr 2026: $31.0M, +41% on a year earlier; public on 6 May 2026
Quarter ended 3 Jul 2026: $32.0M, +10% on a year earlier; public on 5 Aug 2026
Quarter ended 2 Oct 2026: $47.0M, +52% on a year earlier; public on 4 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 463; public on 14 Feb 2022
31 Mar 2022 report: 486; public on 16 May 2022
30 Jun 2022 report: 489; public on 15 Aug 2022
30 Sep 2022 report: 488; public on 14 Nov 2022
31 Dec 2022 report: 532; public on 14 Feb 2023
31 Mar 2023 report: 518; public on 15 May 2023
30 Jun 2023 report: 473; public on 14 Aug 2023
30 Sep 2023 report: 501; public on 14 Nov 2023
31 Dec 2023 report: 570; public on 14 Feb 2024
31 Mar 2024 report: 631; public on 15 May 2024
30 Jun 2024 report: 693; public on 14 Aug 2024
30 Sep 2024 report: 724; public on 14 Nov 2024
31 Dec 2024 report: 787; public on 14 Feb 2025
31 Mar 2025 report: 766; public on 15 May 2025
30 Jun 2025 report: 788; public on 14 Aug 2025
30 Sep 2025 report: 856; public on 14 Nov 2025
31 Dec 2025 report: 906; public on 17 Feb 2026
31 Mar 2026 report: 871; public on 15 May 2026
30 Jun 2026 report: 748; public on 14 Aug 2026
30 Sep 2026 report: 809; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $464.3M published
Month from 1 Dec 2021: $2.2B published
Month from 1 Jan 2022: $280.2M published
Month from 1 Feb 2022: $491.0M published
Month from 1 Mar 2022: $682.4M published
Month from 1 Apr 2022: $447.8M published
Month from 1 May 2022: $462.1M published
Month from 1 Jun 2022: $576.9M published
Month from 1 Jul 2022: $599.9M published
Month from 1 Aug 2022: $871.3M published
Month from 1 Sep 2022: $883.8M published
Month from 1 Oct 2022: $551.8M published
Month from 1 Nov 2022: $714.2M published
Month from 1 Dec 2022: $2.2B published
Month from 1 Jan 2023: $190.6M published
Month from 1 Feb 2023: $656.4M published
Month from 1 Mar 2023: $570.3M published
Month from 1 Apr 2023: $192.6M published
Month from 1 May 2023: $825.3M published
Month from 1 Jun 2023: $1.0B published
Month from 1 Jul 2023: $660.2M published
Month from 1 Aug 2023: $879.0M published
Month from 1 Sep 2023: $812.5M published
Month from 1 Oct 2023: $394.1M published
Month from 1 Nov 2023: $1.0B published
Month from 1 Dec 2023: $2.1B published
Month from 1 Jan 2024: $221.7M published
Month from 1 Feb 2024: $868.7M published
Month from 1 Mar 2024: $648.9M published
Month from 1 Apr 2024: $271.7M published
Month from 1 May 2024: $1.0B published
Month from 1 Jun 2024: $420.1M published
Month from 1 Jul 2024: $374.6M published
Month from 1 Aug 2024: $1.6B published
Month from 1 Sep 2024: $646.1M published
Month from 1 Oct 2024: $725.8M published
Month from 1 Nov 2024: $442.2M published
Month from 1 Dec 2024: $2.3B published
Month from 1 Jan 2025: $284.9M published
Month from 1 Feb 2025: $768.3M published
Month from 1 Mar 2025: $652.2M published
Month from 1 Apr 2025: $396.5M published
Month from 1 May 2025: $499.1M published
Month from 1 Jun 2025: $647.3M published
Month from 1 Jul 2025: $671.5M published
Month from 1 Aug 2025: $446.3M published
Month from 1 Sep 2025: $196.7M published
Month from 1 Oct 2025: $830.2M published
Month from 1 Nov 2025: $1.7B published
Month from 1 Dec 2025: $2.1B published
Month from 1 Jan 2026: $43.7M published
Month from 1 Feb 2026: $648.7M published
Month from 1 Mar 2026: $2.3B published
Month from 1 Apr 2026: $300.1M published
Month from 1 May 2026: $478.7M published
Month from 1 Jun 2026: $672.3M published
Month from 1 Jul 2026: $739.2M published
Month from 1 Aug 2026: $508.9M published
Month from 1 Sep 2026: $849.2M published
Month from 1 Oct 2026: $1.1B published
Month from 1 Nov 2026: $262.6M published
Lobbying spend
Quarter from 1 Jan 2022: $590K published
Quarter from 1 Apr 2022: $750K published
Quarter from 1 Jul 2022: $710K published
Quarter from 1 Oct 2022: $780K published
Quarter from 1 Jan 2023: $770K published
Quarter from 1 Apr 2023: $790K published
Quarter from 1 Jul 2023: $550K published
Quarter from 1 Oct 2023: $560K published
Quarter from 1 Jan 2024: $1.7M published
Quarter from 1 Jul 2024: $990K published
Quarter from 1 Oct 2024: $920K published
Quarter from 1 Jan 2025: $1.2M published
Quarter from 1 Apr 2025: $1.0M published
Quarter from 1 Jul 2025: $1.1M published
Quarter from 1 Oct 2025: $1.3M published
Quarter from 1 Jan 2026: $1.5M published
Quarter from 1 Apr 2026: $1.3M published
Quarter from 1 Jul 2026: $1.1M published
Quarter from 1 Oct 2026: $1.2M published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is H-1B/E-3 applications certified at 0 (Aug 2026), none in the latest month; its normal month is 12.
  • Lobbying on a new issue: lobbying on a new issue Public on 5 Aug 2026.
  • Insider net buying (open market): Insiders sold a net $3.5M in the last 12 months (the 12 months before: -$7.5M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 15 published in the last 12 months (none in the 12 months before).

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 79 insider trades

Last 90 days: 2 sales, $440K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
19 Nov 2026Roy E StevensSector PresidentSellafter exercising options2,287$130.95$299KForm 4
2 Sep 2026Gary Stephen MayDirectorSell1,000$140.85$141KForm 4
13 Aug 2026Noel B GeerDirectorSell10,000$140.66$1.4MForm 4
8 May 2026Gary Stephen MayDirectorSellafter exercising options1,484$132.75$197KForm 4
8 Apr 2026Elizabeth A PorterSector PresidentSellplanned in advance (10b5-1)2,000$158.77$318KForm 4
22 Jan 2026Elizabeth A PorterSector PresidentSellplanned in advance (10b5-1)3,000$192.21$577KForm 4
22 Dec 2025Elizabeth A PorterSector PresidentSellplanned in advance (10b5-1)3,000$181.04$543KForm 4
4 Sep 2025Stephen Edward HullSector PresidentSellafter exercising options12,497$178.14$2.2MForm 4

809 institutions reported shares at the end of Q3 2026, 77% of the shares outstanding; 130 opened a position, 72 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.9.8M8.01%$1.2B-181K-1.8%
Vanguard Capital Management LLC8.2M6.72%$999.2M-13K-0.2%
State Street Corp6.0M4.91%$730.1M-285K-4.5%
Vanguard Portfolio Management LLC5.2M4.24%$629.6M-201K-3.7%
JPMorgan Chase & Co3.9M3.16%$474.1M+18K+0.5%
Geode Capital Management, LLC3.8M3.08%$456.7M+90K+2.4%
First Trust Advisors LP3.1M2.53%$376.6M+315K+11%
AQR Capital Management LLC2.9M2.38%$353.6M+2.1M+251%
Invesco Ltd.2.9M2.35%$348.9M-274K-8.7%
Dimensional Fund Advisors LP2.3M1.89%$280.5M+177K+8.3%

127 new awards in 12 months, $3.3B obligated when signed. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
13 Oct 2026Department of Veterans Affairs$1.3MMEDICAL PROVIDERS AND MOBILE MEDICAL CLINIC (MMC) FOR THE NORTHERN ARIZONA HEALTH CARE SYSTEM (NAVAHCS)USAspending
30 Sep 2026Department of Homeland SecurityU.S. Immigration and Customs Enforcement$15.2Mup to $65.5MIMMIGRATION & CUSTOMS ENFORCEMENT(ICE) ELECTRONIC HEALTH RECORDS BLANKET PURCHASE AGREEMENT(BPA) CALL #1 TO BUILD AN ELECTRONIC HEALTH RECORDS SYSTEM TO BE USED BY ICE FOR HEALTH RECORDS MANAGEMENT.USAspending
29 Sep 2026Department of Health and Human ServicesNational Institutes of Health$72.2MFUNCTIONAL PRECISION MEDICINE AND RESPONSE ASSAYSUSAspending
25 Sep 2026Department of Health and Human ServicesNational Institutes of Health$11.7MPALM004: AN OBSERVATIONAL STUDY OF THE NATURAL HISTORY OF BUNDIBUGYO VIRUS DISEASEUSAspending
24 Sep 2026Department of Health and Human ServicesNational Institutes of Health$17.7MCLINICAL MATERIAL TECHNOLOGY DEVELOPMENT AND PILOT MANUFACTURINGUSAspending
23 Sep 2026Department of Health and Human ServicesNational Institutes of Health$1.7MINTEGRATED DMPK AND TOXICOLOGY PROFILING OF NCATS/TDB MEDICINAL CHEMISTRY LEAD CANDIDATESUSAspending
15 Sep 2026Department of Health and Human ServicesNational Institutes of Health$4.5MNCI-ARCDCTD-26-0055 - CPTAC BIOSPECIMEN ACQUISITION, PROCESSING, AND DISTRIBUTIONUSAspending
14 Sep 2026Department of Health and Human ServicesNational Institutes of Health$1.1MINTEGRATED DMPK AND TOXICOLOGY PROFILING OF NCATS/TDB MEDICINAL CHEMISTRY LEAD CANDIDATESUSAspending

Company events

All 59 company events

In 12 months: 5 major agreements, 2 director or officer changes, 1 completed deal. Results releases and routine reports are left out.

FiledWhat happenedSource
5 Oct 2026Signed a major agreement8-K
1 Oct 2026Director or officer change8-K
6 May 2026Director or officer changeSame filing: shareholder vote results8-K
15 Apr 2026Signed a major agreement8-K
30 Mar 2026Completed an acquisition or asset sale8-K
2 Mar 2026Signed a major agreementSame filing: took on new debt8-K
17 Feb 2026Signed a major agreementSame filing: took on new debt8-K
26 Jan 2026Signed a major agreement8-K

Reported lobbying spend: $1.2M in Q3 2026, $1.1M in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
31 Mar 2026EndedPotomac Capitol Associates, Inc.for Leidos IncHouse and Senate FY2027 National Defense Authorization Act (Bill Numbers TBD); House and Senate FY2027 Intelligence Authorization Act (Bill Numbers TBD); House and Senate FY2027 Defense Appropriations Act (Bill Numbers TBD); House and Senate FY2027 Reconciliation Bill (Name and Bill Numbers TBD); P.DefenseFiling
31 Mar 2026EndedFox Potomac Resources, LLCfor Saiccyber issues and requirements at DOEEnergy, Science/technologyFiling
19 Feb 2025NewSquire Patton Boggsfor Leidos Inc.Issues related to the federal budget and congressional appropriations, including DHS, DOT, VA; National Defense Authorization Act (NDAA).Budget, DefenseFiling
1 Feb 2025NewCGCN Group, LLCfor Leidos, Inc.Issues related to budget, defense, energy, health, homeland security, intelligence, transportation, science/technology, and veterans.Budget, Defense, Energy, Health issues, Homeland security, INT, Transportation, Science/technology, VETFiling
2 Aug 2024NewFox Potomac Resources, LLCfor SaicDepartment of Energy contracting issues and opportunitiesScience/technologyFiling
31 Jan 2024EndedRepublic Consulting, LLCfor SaicNot statedFiling
16 Mar 2023New535 Group, LLCfor Leidos, Inc.Authorization and appropriations requests for various programs.Aviation, Defense, Budget, Homeland securityFiling
17 Feb 2023NewRepublic Consulting, LLCfor SaicMonitor Budget and national Defense Authorization for defense technology policy.DefenseFiling

Layoff notices

All 1 layoff notices

No notice in 12 months; the latest is dated 1 Jul 2005. State WARN notices.

NoticeSiteWorkersJobs endSource
1 Jul 2005SAICPISCATAWAY, NJ6418 Sep 2005Notice

The 5 newest of 365 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

27 Aug 2019confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Leidos (LDOS): saw 84 13F filers open a new position in the quarter ended 30 Jun 2019, 2.7× the same quarter last year, while it had 5.8M shares sold short in the 15 Aug 2019 report, 1.4× the same report last year. Two unrelated kinds of activity within 7 days.

  • Institutional holdings: Many funds opening a new position, became public on 14 Aug 2019
  • Short interest and volume: Short interest spike, became public on 27 Aug 2019
2017-06-30: 462017-09-30: 422017-12-31: 572018-03-31: 502018-06-30: 312018-09-30: 462018-12-31: 342019-03-31: 442019-06-30: 84
The quarter ended 30 Jun 2019 against the 8 quarters before it. this quarterearliernormal: 45
See the evidence (2 changes)

Institutional holdings: Many funds opening a new position became public on 14 Aug 2019

Leidos saw 84 13F filers open a new position in the quarter ended 30 Jun 2019, 2.7× the same quarter last year.

This period
84 (the quarter ended 30 Jun 2019)
Normal quarter (median of 8 earlier)
45
Typical spread (median absolute deviation)
4
How far from its usual level
+6.6
Same quarter last year
31
History used
2,099 days
2017-06-30: 462017-09-30: 422017-12-31: 572018-03-31: 502018-06-30: 312018-09-30: 462018-12-31: 342019-03-31: 442019-06-30: 84
the quarter ended 30 Jun 20198 earlier quartersnormal: 45

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 27 Aug 2019

Leidos had 5.8M shares sold short in the 15 Aug 2019 report, 1.4× the same report last year.

This period
5.8M (the 15 Aug 2019 report)
Normal report (median of 24 earlier)
3.5M
Typical spread (median absolute deviation)
357K
How far from its usual level
+4.4
Same report last year
4.2M
History used
594 days
2018-08-15: 4.2M2018-08-31: 3.3M2018-09-14: 2.8M2018-09-28: 2.9M2018-10-15: 3.1M2018-10-31: 6.3M2018-11-15: 5.0M2018-11-30: 3.9M2018-12-14: 4.3M2018-12-31: 4.2M2019-01-15: 4.0M2019-01-31: 3.5M2019-02-15: 3.9M2019-02-28: 3.4M2019-03-15: 3.3M2019-03-29: 3.4M2019-04-15: 3.3M2019-04-30: 3.8M2019-05-15: 3.2M2019-05-31: 3.2M2019-06-14: 3.0M2019-06-28: 3.6M2019-07-15: 3.4M2019-07-31: 3.8M2019-08-15: 5.8M
the 15 Aug 2019 report24 earlier reportsnormal: 3.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 22 Oct 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract W15P7T26F0215 ($1.3M) (dated 22 Jul 2026)

  2. 21 Oct 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract W15P7T26F0201 ($1.1M) (dated 21 Jul 2026)

  3. 19 Oct 2026Government contracts record

    QTC MEDICAL SERVICES INC: new Department of Veterans Affairs contract 36C26227N0134 ($1.3M) (dated 13 Oct 2026)

  4. 17 Oct 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract N0003926F7275 ($1.3M) (dated 17 Jul 2026)

  5. 17 Oct 2026Government contracts record

    DYNETICS, INC.: new Department of Defense contract FA852326F0010 ($4.5M) (dated 17 Jul 2026)

  6. 16 Oct 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract N0018926FB064 ($3.9M) (dated 16 Jul 2026)

  7. 16 Oct 2026Government contracts record

    QTC MEDICAL SERVICES INC: new Department of Defense contract HT001126FE044 ($1.0M) (dated 16 Jul 2026)

  8. 15 Oct 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract W15P7T26F0183 ($11.4M) (dated 15 Jul 2026)

  9. 10 Oct 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract W15P7T26F0198 ($6.7M) (dated 10 Jul 2026)

  10. 10 Oct 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract HQ072726FE078 ($5.8M) (dated 10 Jul 2026)

  11. 7 Oct 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract HDTRA126FE051 ($1.1M) (dated 7 Jul 2026)

  12. 6 Oct 2026Government contracts record

    LEIDOS, INC.: new Department of Homeland Security contract 70CTD026FC0000061 ($15.2M) (dated 30 Sep 2026)

  13. 5 Oct 2026Government contracts record

    LEIDOS BIOMEDICAL RESEARCH INC: new Department of Health and Human Services contract 75N91026F00034 ($72.2M) (dated 29 Sep 2026)

  14. 2 Oct 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract W15P7T26F0156 ($2.2M) (dated 2 Jul 2026)

  15. 2 Oct 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract W15P7T26F0122 ($1.8M) (dated 2 Jul 2026)

  16. 1 Oct 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 1 Oct 2026Filings record

    Director or officer change

  18. 1 Oct 2026Government contracts record

    LEIDOS BIOMEDICAL RESEARCH INC: new Department of Health and Human Services contract 75N91026F00033 ($11.7M) (dated 25 Sep 2026)

  19. 30 Sep 2026Government contracts record

    LEIDOS BIOMEDICAL RESEARCH INC: new Department of Health and Human Services contract 75N91026F00032 ($17.7M) (dated 24 Sep 2026)

  20. 30 Sep 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract N6883626F7PQ6 ($1.5M) (dated 30 Jun 2026)

  21. 30 Sep 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract N6883626F7PPQ ($1.1M) (dated 30 Jun 2026)

  22. 30 Sep 2026Government contracts record

    QTC MEDICAL SERVICES INC: new Department of Defense contract HT001126FE032 ($1.0M) (dated 30 Jun 2026)

  23. 30 Sep 2026Government contracts record

    QTC MEDICAL SERVICES INC: new Department of Defense contract HT001126FE025 ($7.0M) (dated 30 Jun 2026)

  24. 29 Sep 2026Government contracts record

    LEIDOS BIOMEDICAL RESEARCH INC: new Department of Health and Human Services contract 75N91026F00026 ($1.7M) (dated 23 Sep 2026)

  25. 29 Sep 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract N0003926F7265 ($2.0M) (dated 29 Jun 2026)

  26. 25 Sep 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract W15P7T26F0172 ($5.2M) (dated 25 Jun 2026)

  27. 24 Sep 2026Government contracts record

    QTC MEDICAL SERVICES INC: new Department of Defense contract HT001126FE028 ($1.8M) (dated 24 Jun 2026)

  28. 24 Sep 2026Government contracts record

    QTC MEDICAL SERVICES INC: new Department of Defense contract HT001126FE024 ($18.0M) (dated 24 Jun 2026)

  29. 24 Sep 2026Government contracts record

    QTC MEDICAL SERVICES INC: new Department of Defense contract HT001126FE023 ($3.2M) (dated 24 Jun 2026)

  30. 23 Sep 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract W15P7T26F0159 ($1.1M) (dated 23 Jun 2026)

  31. 23 Sep 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract N0018926FB033 ($2.4M) (dated 23 Jun 2026)

  32. 22 Sep 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract W909MY26F0023 ($5.9M) (dated 22 Jun 2026)

  33. 21 Sep 2026Government contracts record

    LEIDOS BIOMEDICAL RESEARCH INC: new Department of Health and Human Services contract 75N91026F00020 ($4.5M) (dated 15 Sep 2026)

  34. 20 Sep 2026Government contracts record

    LEIDOS BIOMEDICAL RESEARCH INC: new Department of Health and Human Services contract 75N91026F00027 ($1.1M) (dated 14 Sep 2026)

  35. 17 Sep 2026Government contracts record

    LEIDOS, INC.: new General Services Administration contract 47QFMA26F0007 ($9.7M) (dated 11 Sep 2026)

  36. 17 Sep 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract N0003926F7260 ($7.6M) (dated 17 Jun 2026)

  37. 16 Sep 2026Government contracts record

    LEIDOS BIOMEDICAL RESEARCH INC: new Department of Health and Human Services contract 75N91026F00024 ($1.3M) (dated 10 Sep 2026)

  38. 14 Sep 2026Government contracts record

    LEIDOS BIOMEDICAL RESEARCH INC: new Department of Health and Human Services contract 75N91026F00021 ($1.3M) (dated 8 Sep 2026)

  39. 14 Sep 2026Government contracts record

    QTC MEDICAL SERVICES INC: new Department of the Interior contract 140D0426F1053 ($2.5M) (dated 8 Sep 2026)

  40. 11 Sep 2026Government contracts record

    LEIDOS, INC.: new Department of Defense contract N0001426C1120 ($2.3M) (dated 11 Jun 2026)

Showing the newest 40 of 158 entries; narrow the window or the kind of data to see older ones.

Not listed: 198 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001336920
Ticker
LDOS
Domain
leidos.com
Employer name
leidos, Leidos Biomedical Research, Inc., leidos engineering, SAIC (3 unverified)
Fein
33-0653185 (1 unverified)
Hq location
VA|RESTON|20190 (1 unverified)
Lobbying client
jefferson business consulting on behalf of leidos, leidos, leidos holdings, leidos inc fka science applications international corporation or saic and 2 more
Name
1901 Group, LLC, Dynetics, Inc, Dynetics Technical Solutions, Inc, Gibbs & Cox, Inc and 21 more
Uei
ZL41ERXMPAR3
Wikidata
Q502132
Wikipedia
Leidos
  • DOL H-1B labor condition applications and PERM certifications68 data points17 Nov 2025 to 14 Sep 2026
  • Federal lobbying disclosures (LDA)75 records, 279 data points30 Jun 1999 to 30 Sep 2026
  • SEC Form 13F institutional holdings2 records, 477 data points30 Sep 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)166 records26 Jan 2016 to 3 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1092 data points31 Jan 2008 to 27 Oct 2026
  • SEC Form 4 insider transactions79 records, 284 data points4 Mar 2016 to 19 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards4430 records, 17714 data points1 Oct 2007 to 20 Nov 2026
  • WARN layoff notices (state labor agencies)1 record, 3 data points27 Jun 2005 to 1 Jul 2005
  • Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026